Cleared Traditional

GammaTile

K221539 · Gt Medical Technologies · Radiology
Nov 2022
Decision
166d
Days
Class 2
Risk

About This 510(k) Submission

K221539 is an FDA 510(k) clearance for the GammaTile, a Source, Brachytherapy, Radionuclide (Class II — Special Controls, product code KXK), submitted by Gt Medical Technologies (Tempe, US). The FDA issued a Cleared decision on November 9, 2022, 166 days after receiving the submission on May 27, 2022. This device falls under the Radiology review panel. Regulated under 21 CFR 892.5730.

Submission Details

510(k) Number K221539 FDA.gov
FDA Decision Cleared SESE
Date Received May 27, 2022
Decision Date November 09, 2022
Days to Decision 166 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code KXK — Source, Brachytherapy, Radionuclide
Device Class Class II — Special Controls
CFR Regulation 21 CFR 892.5730

Similar Devices — KXK Source, Brachytherapy, Radionuclide

All 150
OncoPatch
K252296 · Oncopatch, Inc. · Dec 2025
IsoSphere
K242818 · Isoaid, LLC · Jul 2025
RadianceTx Radionuclide Brachytherapy Source
K223465 · Radiance Therapeutics, Inc. · Jan 2023
Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles
K202267 · Isoray Medical, Inc. · Dec 2020
LV Liberty Vision Model 1 90Yttrium Brachytherapy Source
K193602 · Lv Liberty Vision Corporation · May 2020
GammaTile
K190839 · Gt Medical Technologies · Jan 2020